Skip to Menu Skip to Search Contact Us Global Websites & Languages Skip to Content

Oncology clinical research services from SGS – a comprehensive range of services, from strategic consultancy to clinical trial execution.

Clinical therapeutic areas

Clinical research and drug development for oncology requires extensive expertise, resources, and cross-disciplinary support. We offer small and mid-size biotechs and pharma clients a one-stop solution, including access to patients and expertise through our sophisticated oncology site network and comprehensive services, providing you with:

  • Strategic direction
  • Full-time oncologists
  • Unique early phase capabilities
  • Global monitoring reach
  • A specialized biometrics group
  • Flexibility and responsiveness

Why choose oncology clinical research services from SGS?

Benefit from our extensive oncology drug development experience

Our experience extends to over 150 oncology drug development projects for a wide variety of anti-cancer drugs covering a broad range of tumor types.

Access a team of dedicated oncology specialists

With a dedicated and experienced oncology team of medical specialists, clinical and biometric project managers, and CRAs, we develop customized solutions, adapting to your needs. Plus, our oncology project director is a board-certified oncologist with over 20 years of clinical research (Phase I-III) and therapeutic (head and neck cancer) experience.

Enroll the right patients for your clinical trial programs

We offer you solid patient recruitment capabilities. We combine our extensive site network with exclusive patient center and hospital partnerships, using SGS-experienced medical staff who work with our robust and proven quality system. As a result, we can address the specific needs and complexities of your oncology clinical trial programs.

Plus, our strategic partnership with SMS-oncology – a Netherlands-based CRO – provides you with added expert consultants. As a result, we can offer you the full scope of oncology clinical trial services – from consultancy and market dossier submission to specialized hospital access to enable you to find the right patients for each clinical trial program.

Rely on our solid oncology clinical research expertise

We offer you a wide-range of compound expertise, which includes large and small molecules, immune therapies, vaccines, vectors, adjuvants, chemo generics, biosimilars, and oncosupportive drugs in several drug classes and indications, such as:

Drug classes:

  • Monoclonal antibody
  • Oligonucleotide
  • Anthracycline
  • Cell therapy
  • Gene therapy
  • Vaccine
  • Biomarker
  • Hormone
  • Opioid
  • Photosensitizing agent
  • Radiolabeled protein

Cancer Indications:

  • Breast
  • Ovarian
  • Cervical
  • Prostate
  • Colorectal
  • Gastro-Entero-Pancreatic
  • Kidney
  • Brain (brain metastasis, Glioblastoma)
  • Neuroendocrine
  • Head and neck
  • Sarcoma
  • Lung
  • Melanoma
  • AML
  • Lymphoma

A Range of World-Leading Oncology Clinical Research Services

As an international mid-size CRO, SGS is recognized as the benchmark clinical research partner for quality, reliability, flexibility and customer care. Our comprehensive range of oncology services includes:

  • Consultancy: such as preclinical and clinical data reviews, regulatory submission strategy input, organizing scientific advisory boards with oncology experts
  • Clinical development planning: including target profile, product positioning, and Phase I design and synopsis
  • Phase I-IV clinical trials
  • Biometrics services
  • Pharmacovigilance: support for drug safety and post-registration surveillance services
  • Bioanalytical laboratory services: such as biosafety and immuno cell-based assays, cancer biomarkers, Pharmacokinetics (PK)and Pharmacodynamics (PD)

To discuss your oncology drug development program, contact us today.